Systolic aortic regurgitation predicts all-cause mortality and hospitalization in outpatients with heart failure and preserved ejection fraction
Yıl: 2020 Cilt: 7 Sayı: 4 Sayfa Aralığı: 335 - 340 Metin Dili: İngilizce DOI: 10.14744/nci.2020.56750 İndeks Tarihi: 18-09-2020
Systolic aortic regurgitation predicts all-cause mortality and hospitalization in outpatients with heart failure and preserved ejection fraction
Öz: OBJECTIVE: Systolic aortic regurgitation (SAR) is considered to be a specific sign of heart failure (HF). However, the prevalence and importance of SAR in patients with HF and preserved ejection fraction (HFpEF) are unknown. Therefore, we soughtto examine the prevalence of SAR in HFpEF outpatients and its association with all-cause mortality and/or cardiovascularhospitalizations during a 1-year follow-up.METHODS: We enrolled 301 consecutive outpatients with HFpEF (mean age of 67.3±9.6 years, 53.5% women) and prospectively followed up for one year. Demographic, clinical, echocardiographic, and laboratory data were obtained at study entry.The composite endpoint of this study was all-cause mortality or HF-related hospitalizations in one year.RESULTS: SAR was noted in 30 (9.9%) of the patients, and 38 patients (12.6%) reached the primary endpoint. The primarycomposite endpoint in one year was higher for the patients with SAR (26.3%) compared to the patients without SAR (7.6%,p<0.001). After adjusting for important covariates, SAR remained independently associated with primary outcome (OR 2.315;95% CI 1.188–5.477; p=0.008).CONCLUSION: To our knowledge, this is the first study to demonstrate that the presence of SAR is associated with adverse events in patients with HFpEF
Anahtar Kelime: Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
- 1. Oren O, Goldberg S. Heart Failure with Preserved Ejection Fraction: Diagnosis and Management. Am J Med 2017;130:510–6.
- 2. Özlek B, Özlek E, Ağuş HZ, Tekinalp M, Kahraman S, Çil C, et al. Patients with HFpEF and HFmrEF have different clinical characteristics in Turkey: A multicenter observational study. Eur J Intern Med 2019;61:88–95.
- 3. Yee D, Novak E, Platts A, Nassif ME, LaRue SJ, Vader JM. Comparison of the Kansas City Cardiomyopathy Questionnaire and Minnesota Living With Heart Failure Questionnaire in Predicting Heart Failure Outcomes. Am J Cardiol 2019;123:807–12.
- 4. Hashimoto H, Nakanishi R, Mizumura S, Hashimoto Y, Okamura Y, Kiuchi S, et al. Prognostic Value of 123I-BMIPP SPECT in Patients with Nonischemic Heart Failure with Preserved Ejection Fraction. J Nucl Med 2018;59:259–65.
- 5. Nikolova AP, Hitzeman TC, Baum R, Caldaruse AM, Agvanian S, Xie Y, et al. Association of a Novel Diagnostic Biomarker, the Plasma Cardiac Bridging Integrator 1 Score, With Heart Failure With Preserved Ejection Fraction and Cardiovascular Hospitalization. JAMA Cardiol 2018;3:1206–10.
- 6. Ohtani T, Mohammed SF, Yamamoto K, Dunlay SM, Weston SA, Sakata Y, et al. Diastolic stiffness as assessed by diastolic wall strain is associated with adverse remodelling and poor outcomes in heart failure with preserved ejection fraction. Eur Heart J 2012;33:1742–9.
- 7. Lam CS, Roger VL, Rodeheffer RJ, Borlaug BA, Enders FT, Redfield MM. Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study. J Am Coll Cardiol 2009;53:1119– 26.
- 8. Burke MA, Katz DH, Beussink L, Selvaraj S, Gupta DK, Fox J, et al. Prognostic importance of pathophysiologic markers in patients with heart failure and preserved ejection fraction. Circ Heart Fail 2014;7:288–99.
- 9. Duyuler S, Türker Duyuler P. Accentuating systolic aortic regurgitation during premature ventricular systole. Anatol J Cardiol 2017;18:E3–4.
- 10. Mohan JC, Mohan V, Shukla M, Sethi A. Systolic aortic regurgitation in rheumatic carditis: Mechanistic insight by Doppler echocardiography. Indian Heart J 2018;70:272–7.
- 11. Saura D, Peñafiel P, Martínez J, de la Morena G, García-Alberola A, Soria F, et al. The frequency of systolic aortic regurgitation and its relationship to heart failure in a consecutive series of patients. [Article in Spanish]. Rev Esp Cardiol 2008;61:771–4.
- 12. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al; ESC Scientific Document Group. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016;37:2129–200.
- 13. Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 2010;23:685–713.
- 14. Özlek B, Özlek E, Tekinalp M, Kahraman S, Ağuş HZ, Çelik O, et al. Clinical features of heart failure with mid-range and preserved ejection fraction in octogenarians: Results of a multicentre, observational study. Int J Clin Pract 2019;73:e13341.
- 15. Voors AA, Ouwerkerk W, Zannad F, van Veldhuisen DJ, Samani NJ, Ponikowski P, et al. Development and validation of multivariable models to predict mortality and hospitalization in patients with heart failure. Eur J Heart Fail 2017;19:627–34.
- 16. Saura D, López-Cuenca A, Oliva MJ, Caballero L, González-Carrillo J, Espinosa MD, et al. Accuracy of systolic aortic regurgitation in the diagnosis of heart failure: a predictive approach. Int J Clin Pract 2015;69:485–90.
- 17. Bonaque JC, Sánchez-Espino AD, Merchán G, González-Juanatey JR. Systolic aortic regurgitation. A new prognostic marker in heart failure patients?. Rev Esp Cardiol (Engl Ed) 2015;68:160–2.
| APA | Bolat İ, BİTEKER M (2020). Systolic aortic regurgitation predicts all-cause mortality and hospitalization in outpatients with heart failure and preserved ejection fraction. , 335 - 340. 10.14744/nci.2020.56750 |
| Chicago | Bolat İsmail,BİTEKER MURAT Systolic aortic regurgitation predicts all-cause mortality and hospitalization in outpatients with heart failure and preserved ejection fraction. (2020): 335 - 340. 10.14744/nci.2020.56750 |
| MLA | Bolat İsmail,BİTEKER MURAT Systolic aortic regurgitation predicts all-cause mortality and hospitalization in outpatients with heart failure and preserved ejection fraction. , 2020, ss.335 - 340. 10.14744/nci.2020.56750 |
| AMA | Bolat İ,BİTEKER M Systolic aortic regurgitation predicts all-cause mortality and hospitalization in outpatients with heart failure and preserved ejection fraction. . 2020; 335 - 340. 10.14744/nci.2020.56750 |
| Vancouver | Bolat İ,BİTEKER M Systolic aortic regurgitation predicts all-cause mortality and hospitalization in outpatients with heart failure and preserved ejection fraction. . 2020; 335 - 340. 10.14744/nci.2020.56750 |
| IEEE | Bolat İ,BİTEKER M "Systolic aortic regurgitation predicts all-cause mortality and hospitalization in outpatients with heart failure and preserved ejection fraction." , ss.335 - 340, 2020. 10.14744/nci.2020.56750 |
| ISNAD | Bolat, İsmail - BİTEKER, MURAT. "Systolic aortic regurgitation predicts all-cause mortality and hospitalization in outpatients with heart failure and preserved ejection fraction". (2020), 335-340. https://doi.org/10.14744/nci.2020.56750 |
| APA | Bolat İ, BİTEKER M (2020). Systolic aortic regurgitation predicts all-cause mortality and hospitalization in outpatients with heart failure and preserved ejection fraction. İstanbul Kuzey Klinikleri, 7(4), 335 - 340. 10.14744/nci.2020.56750 |
| Chicago | Bolat İsmail,BİTEKER MURAT Systolic aortic regurgitation predicts all-cause mortality and hospitalization in outpatients with heart failure and preserved ejection fraction. İstanbul Kuzey Klinikleri 7, no.4 (2020): 335 - 340. 10.14744/nci.2020.56750 |
| MLA | Bolat İsmail,BİTEKER MURAT Systolic aortic regurgitation predicts all-cause mortality and hospitalization in outpatients with heart failure and preserved ejection fraction. İstanbul Kuzey Klinikleri, vol.7, no.4, 2020, ss.335 - 340. 10.14744/nci.2020.56750 |
| AMA | Bolat İ,BİTEKER M Systolic aortic regurgitation predicts all-cause mortality and hospitalization in outpatients with heart failure and preserved ejection fraction. İstanbul Kuzey Klinikleri. 2020; 7(4): 335 - 340. 10.14744/nci.2020.56750 |
| Vancouver | Bolat İ,BİTEKER M Systolic aortic regurgitation predicts all-cause mortality and hospitalization in outpatients with heart failure and preserved ejection fraction. İstanbul Kuzey Klinikleri. 2020; 7(4): 335 - 340. 10.14744/nci.2020.56750 |
| IEEE | Bolat İ,BİTEKER M "Systolic aortic regurgitation predicts all-cause mortality and hospitalization in outpatients with heart failure and preserved ejection fraction." İstanbul Kuzey Klinikleri, 7, ss.335 - 340, 2020. 10.14744/nci.2020.56750 |
| ISNAD | Bolat, İsmail - BİTEKER, MURAT. "Systolic aortic regurgitation predicts all-cause mortality and hospitalization in outpatients with heart failure and preserved ejection fraction". İstanbul Kuzey Klinikleri 7/4 (2020), 335-340. https://doi.org/10.14744/nci.2020.56750 |
